United Therapeutics CEO Martine A. Rothblatt disposes of shares worth $4,287,172.85

UTHR•2026-09-30

United Therapeutics Chairperson and CEO Martine A. Rothblatt reported an option exercise and stock sales on Sept. 29, 2026. A family trust exercised options for 9,500 shares at $117.76 and sold those shares at prices from $472.0452 to $486.77.

1. Trust transactions

The family trust’s common stock position ended at 324,443 shares, and its stock options ended at 337,910, exercisable at $117.76.

Sources

United Therapeutics CEO Martine A. Rothblatt disposes of shares worth $4,287,172.85

Sec

United Therapeutics CEO Martine A. Rothblatt disposes of shares worth $4,287,172.85

1. Trust transactions

Related News

First Citizens BancShares schedules third-quarter earnings call

Youlife Group names Haijun Zhang acting CFO, adds him to board after Yao resignation

Children’s Place draws $25 million subordinated term loan from Mithaq Capital SPC

Sources

United Therapeutics CEO Martine A. Rothblatt disposes of shares worth $4,287,172.85

Enerflex publishes update to financial calendar

Nu says it is not pursuing Monzo transaction amid media speculation